Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Lymphoma 27Leukemia 16Lung Neoplasms 13Neuroblastoma 12Burkitt Lymphoma 11Lymphoma, Large B-Cell, Diffuse 10Hodgkin Disease 10Sarcoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Central Nervous System Neoplasms 9Brain Neoplasms 9Teratoma 8Carcinoma, Non-Small-Cell Lung 7Wilms Tumor 6Neuroectodermal Tumors, Primitive, Peripheral 6Leukemia, Myeloid, Acute 6Testicular Neoplasms 5Lymphoma, Non-Hodgkin 5Ovarian Neoplasms 4Medulloblastoma 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Endodermal Sinus Tumor 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Embryonal 4Sarcoma, Ewing 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Amifostine 4Cisplatin 3Radiotherapy 2Paclitaxel 2Filgrastim 2Carboplatin 2Peripheral Blood Stem Cell Transplantation 1Octreotide 1Melphalan 1Furosemide 1Etoposide 1Erythropoietin 1Epoetin Alfa 1Duloxetine Hydrochloride 1Brachytherapy 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Etoposide × Clear all
NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
27 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡